![dr peacock baylor college of medicine email dr peacock baylor college of medicine email](https://epmgaa.media.clients.ellingtoncms.com/img/photos/2014/10/27/Dr._Massimo_Pietropaolo.jpg)
![dr peacock baylor college of medicine email dr peacock baylor college of medicine email](https://www.baylor.edu/content/imglib/2/5/5/25524.jpg)
Treprostinil for the treatment of pulmonary arterial hypertension in patients onīackground endothelin receptor antagonist and/or phosphodiesterase type 5 PubMed PMID: 22661451.Ĥ: Tapson VF, Torres F, Kermeen F, Keogh AM, Allen RP, Frantz RP, Badesch DB,įrost AE, Shapiro SM, Laliberte K, Sigman J, Arneson C, Galiè N. DemographicsĪnd outcomes of patients diagnosed with pulmonary hypertension with pulmonaryĬapillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.Ĭhest. PubMed PMID: 22955290.ģ: Frost AE, Farber HW, Barst RJ, Miller DP, Elliott CG, McGoon MD. PubMedĢ: Benza RL, Gomberg-Maitland M, Frost AE, Frantz RP, Humbert M, McGoon MD.ĭevelopment of prognostic tools in pulmonary arterial hypertension: lessons from Mesylate as Add-On Therapy for Pulmonary Arterial Hypertension: Results of the Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn DA, Ghofrani HA. MA, Grimminger F, Grünig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T,